199 related articles for article (PubMed ID: 17697410)
21. Within-session practice effect on paced auditory serial addition test in multiple sclerosis.
Nagels G; D'hooghe MB; Kos D; Engelborghs S; De Deyn PP
Mult Scler; 2008 Jan; 14(1):106-11. PubMed ID: 17893110
[TBL] [Abstract][Full Text] [Related]
22. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
Forn C; Belenguer A; Parcet-Ibars MA; Avila C
J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
[TBL] [Abstract][Full Text] [Related]
23. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.
Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Gruszka E; Bilinska M; Podemski R
Clin Neurol Neurosurg; 2009 Jul; 111(6):503-6. PubMed ID: 19233546
[TBL] [Abstract][Full Text] [Related]
24. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
Flechter S; Vardi J; Finkelstein Y; Pollak L
Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
[TBL] [Abstract][Full Text] [Related]
25. The Computerized Test of Information Processing (CTIP) offers an alternative to the PASAT for assessing cognitive processing speed in individuals with multiple sclerosis.
Tombaugh TN; Berrigan LI; Walker LA; Freedman MS
Cogn Behav Neurol; 2010 Sep; 23(3):192-8. PubMed ID: 20829669
[TBL] [Abstract][Full Text] [Related]
26. Evaluating processing speed in multiple sclerosis: a comparison of two rapid serial processing measures.
Lynch SG; Dickerson KJ; Denney DR
Clin Neuropsychol; 2010 Aug; 24(6):963-76. PubMed ID: 20640970
[TBL] [Abstract][Full Text] [Related]
27. Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts.
Roca M; Torralva T; Meli F; Fiol M; Calcagno M; Carpintiero S; De Pino G; Ventrice F; Martín M; Vita L; Manes F; Correale J
Mult Scler; 2008 Apr; 14(3):364-9. PubMed ID: 18208880
[TBL] [Abstract][Full Text] [Related]
28. Specificity of frontal dysfunctions in relapsing-remitting multiple sclerosis.
Santiago O; Guàrdia J; Casado V; Carmona O; Arbizu T
Arch Clin Neuropsychol; 2007 Jun; 22(5):623-9. PubMed ID: 17482795
[TBL] [Abstract][Full Text] [Related]
29. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
30. Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Bosma LV; Kragt JJ; Brieva L; Khaleeli Z; Montalban X; Polman CH; Thompson AJ; Tintoré M; Uitdehaag BM
Mult Scler; 2010 Jul; 16(7):862-7. PubMed ID: 20488826
[TBL] [Abstract][Full Text] [Related]
31. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study.
Scherer P; Penner IK; Rohr A; Boldt H; Ringel I; Wilke-Burger H; Burger-Deinerth E; Isakowitsch K; Zimmermann M; Zahrnt S; Hauser R; Hilbert K; Tiel-Wilck K; Anvari K; Behringer A; Peglau I; Friedrich H; Plenio A; Benesch G; Ehret R; Nippert I; Finke G; Schulz I; Bergtholdt B; Breitkopf S; Kaskel P; Reischies F; Kugler J
Mult Scler; 2007 Apr; 13(3):402-11. PubMed ID: 17439910
[TBL] [Abstract][Full Text] [Related]
32. PASAT in detecting cognitive impairment in relapsing-remitting MS.
Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
Appl Neuropsychol; 2007; 14(2):101-12. PubMed ID: 17523884
[TBL] [Abstract][Full Text] [Related]
33. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
34. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
Denney DR; Lynch SG; Parmenter BA
J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT).
Tombaugh TN
Arch Clin Neuropsychol; 2006 Jan; 21(1):53-76. PubMed ID: 16290063
[TBL] [Abstract][Full Text] [Related]
36. Working memory deficits in multiple sclerosis: comparison between the n-back task and the Paced Auditory Serial Addition Test.
Parmenter BA; Shucard JL; Benedict RH; Shucard DW
J Int Neuropsychol Soc; 2006 Sep; 12(5):677-87. PubMed ID: 16961949
[TBL] [Abstract][Full Text] [Related]
37. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.
Amato MP; Portaccio E; Goretti B; Zipoli V; Iudice A; Della Pina D; Malentacchi G; Sabatini S; Annunziata P; Falcini M; Mazzoni M; Mortilla M; Fonda C; De Stefano N;
Mult Scler; 2010 Dec; 16(12):1474-82. PubMed ID: 20729256
[TBL] [Abstract][Full Text] [Related]
38. Within session practice effects on the PASAT in clients with multiple sclerosis.
Barker-Collo SL
Arch Clin Neuropsychol; 2005 Mar; 20(2):145-52. PubMed ID: 15708724
[TBL] [Abstract][Full Text] [Related]
39. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
40. Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study.
Jønsson A; Andresen J; Storr L; Tscherning T; Soelberg Sørensen P; Ravnborg M
J Neurol Sci; 2006 Jun; 245(1-2):77-85. PubMed ID: 16647089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
